CARA THERAPEUTICS INC. - COMMON STOCK
0.3051
22-November-24 15:44:58
15 minutes delayed
Stocks
-0.0049
-1.58%
Today's range
0.2831 - 0.3160
ISIN
N/A
Source
NASDAQ
-
28 Sep 2022 06:00:01 By Nasdaq GlobeNewswire
-
Cara Therapeutics Appoints Ryan Maynard as Chief Financial Officer
12 Sep 2022 06:00:00 By Nasdaq GlobeNewswire
-
08 Sep 2022 07:15:00 By Nasdaq GlobeNewswire
-
Cara Therapeutics to Present at the H.C. Wainwright 24th Annual Global Investment Conference
06 Sep 2022 06:00:01 By Nasdaq GlobeNewswire
-
Cara Therapeutics to Host Virtual Notalgia Paresthetica Event on September 20, 2022
24 Aug 2022 06:00:00 By Nasdaq GlobeNewswire
-
22 Aug 2022 06:00:00 By Nasdaq GlobeNewswire
-
Kapruvia® approved in Switzerland with additional regulatory decisions expected in H2 2022
19 Aug 2022 00:00:00 By Nasdaq GlobeNewswire
-
Cara Therapeutics Reports Second Quarter 2022 Financial Results
08 Aug 2022 15:01:00 By Nasdaq GlobeNewswire
-
Cara Therapeutics to Present at the Canaccord Genuity 42nd Annual Growth Conference
03 Aug 2022 06:00:01 By Nasdaq GlobeNewswire
-
Cara Therapeutics to Announce Second Quarter 2022 Financial Results on August 8, 2022
01 Aug 2022 15:01:00 By Nasdaq GlobeNewswire
-
30 Jun 2022 06:00:00 By Nasdaq GlobeNewswire
-
Cara Therapeutics to Present at Upcoming Investor Conferences
17 May 2022 06:00:02 By Nasdaq GlobeNewswire
-
Cara Therapeutics Reports First Quarter 2022 Financial Results
09 May 2022 15:01:00 By Nasdaq GlobeNewswire
-
Cara Therapeutics to Present at May Investor Conferences
03 May 2022 15:01:00 By Nasdaq GlobeNewswire
-
Cara Therapeutics to Announce First Quarter 2022 Financial Results on May 9, 2022
29 Apr 2022 06:00:00 By Nasdaq GlobeNewswire
-
28 Apr 2022 00:00:00 By Nasdaq GlobeNewswire
-
Cara Therapeutics to Present at the 21st Annual Needham Virtual Healthcare Conference
05 Apr 2022 06:00:01 By Nasdaq GlobeNewswire
-
28 Mar 2022 06:00:00 By Nasdaq GlobeNewswire
-
08 Mar 2022 15:01:00 By Nasdaq GlobeNewswire